Truist Financial adjusted its rating and TD Cowen lifted its target price for Exelixis stock.
2 reports, 2 independent
Updated Nov 2
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist Financial adjusted its rating and TD Cowen lifted its target price for Exelixis stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Exelixis
American biotechnology company